Literature DB >> 28825204

Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Neha Raghavan1,2,3, Giuseppe Tosto4,5,6.   

Abstract

PURPOSE OF REVIEW: We aimed to summarize the recent advances in genetic findings of Alzheimer's disease (AD), focusing on traditional single-marker and gene approaches and non-traditional ones, i.e., polygenic and epistatic components. RECENT
FINDINGS: Genetic studies have progressed over the last few decades from linkage to genome-wide association studies (GWAS), and most recently studies utilizing high-throughput sequencing. So far, GWASs have identified several common variants characterized by small effect sizes (besides APOE-ε4). Sequencing has facilitated the study of rare variants with larger effects. Nevertheless, missing heritability for AD remains extensive; a possible explanation might lie in the existence of polygenic and epistatic components. We review findings achieved by single-marker approaches, but also polygenic and epistatic associations. The latter two are critical, yet-underexplored mechanisms. Genes involved in complex diseases are likely regulated by mechanisms and pathways involving many other genes, an aspect potentially missed by traditional approaches.

Entities:  

Keywords:  Epistasis; GWAS; Next-generation sequencing; Polygenic risk score

Mesh:

Substances:

Year:  2017        PMID: 28825204      PMCID: PMC5699909          DOI: 10.1007/s11910-017-0787-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  88 in total

1.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

2.  PLD3 gene variants and Alzheimer's disease.

Authors:  Basavaraj V Hooli; Christina M Lill; Kristina Mullin; Dandi Qiao; Christoph Lange; Lars Bertram; Rudolph E Tanzi
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

3.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

4.  Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.

Authors:  E Rodríguez-Rodríguez; P Sánchez-Juan; J L Vázquez-Higuera; I Mateo; A Pozueta; J Berciano; S Cervantes; D Alcolea; P Martínez-Lage; J Clarimón; A Lleó; P Pastor; O Combarros
Journal:  J Neural Transm (Vienna)       Date:  2012-11-20       Impact factor: 3.575

5.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

Authors:  Andrew Grupe; Richard Abraham; Yonghong Li; Charles Rowland; Paul Hollingworth; Angharad Morgan; Luke Jehu; Ricardo Segurado; David Stone; Eric Schadt; Maha Karnoub; Petra Nowotny; Kristina Tacey; Joseph Catanese; John Sninsky; Carol Brayne; David Rubinsztein; Michael Gill; Brian Lawlor; Simon Lovestone; Peter Holmans; Michael O'Donovan; John C Morris; Leon Thal; Alison Goate; Michael J Owen; Julie Williams
Journal:  Hum Mol Genet       Date:  2007-02-22       Impact factor: 6.150

6.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

7.  F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7.

Authors:  Y Liu; T Lear; Y Zhao; J Zhao; C Zou; B B Chen; R K Mallampalli
Journal:  Cell Death Dis       Date:  2015-02-05       Impact factor: 8.469

8.  Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Authors:  Elizabeth C Mormino; Reisa A Sperling; Avram J Holmes; Randy L Buckner; Philip L De Jager; Jordan W Smoller; Mert R Sabuncu
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

9.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

10.  Epistatic genetic effects among Alzheimer's candidate genes.

Authors:  Timothy J Hohman; Mary Ellen Koran; Tricia Thornton-Wells
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more
  19 in total

1.  Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?

Authors:  Polyxeni Stamati; Vasileios Siokas; Athina-Maria Aloizou; Emmanouil Karampinis; Stylianos Arseniou; Valerii N Rakitskii; Aristidis Tsatsakis; Demetrios A Spandidos; Illana Gozes; Panayiotis D Mitsias; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

Review 2.  Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Lancet Neurol       Date:  2020-01-24       Impact factor: 44.182

3.  Evaluation of the Genetic Variance of Alzheimer's Disease Explained by the Disease-Associated Chromosomal Regions.

Authors:  Alireza Nazarian; Alexander M Kulminski
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

5.  Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  Geroscience       Date:  2019-05-05       Impact factor: 7.713

6.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.

Authors:  Elizabeth Vance; Josue D Gonzalez Murcia; Justin B Miller; Lyndsay Staley; Paul K Crane; Shubhabrata Mukherjee; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2020-02-12       Impact factor: 4.673

7.  Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults.

Authors:  Sarah Prieto; Kate E Valerio; Jena N Moody; Scott M Hayes; Jasmeet P Hayes
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  The MUC6/AP2A2 Locus and Its Relevance to Alzheimer's Disease: A Review.

Authors:  Peter T Nelson; David W Fardo; Yuriko Katsumata
Journal:  J Neuropathol Exp Neurol       Date:  2020-06-01       Impact factor: 3.685

9.  Interplay between stress-related genes may influence Alzheimer's disease development: The results of genetic interaction analyses of human data.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin Arbeev; Olivia Bagley; Igor Akushevich; Matt Duan; Arseniy Yashkin; Svetlana Ukraintseva
Journal:  Mech Ageing Dev       Date:  2021-03-30       Impact factor: 5.498

Review 10.  Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.

Authors:  Helen A Rowland; Nigel M Hooper; Katherine A B Kellett
Journal:  Neurochem Res       Date:  2018-11-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.